Albumin and Derived Neutrophil-to-Lymphocyte Ratio is a Novel Prognostic Factor for Patients with Esophageal Squamous Cell Carcinoma

被引:8
|
作者
Abe, Tomoki [1 ]
Oshikiri, Taro [1 ]
Goto, Hironobu [1 ]
Kato, Takashi [1 ]
Horikawa, Manabu [1 ]
Sawada, Ryuichiro [1 ]
Harada, Hitoshi [1 ]
Urakawa, Naoki [1 ]
Hasegawa, Hiroshi [1 ]
Kanaji, Shingo [1 ]
Yamashita, Kimihiro [1 ]
Matsuda, Takeru [2 ]
Nakamura, Tetsu [1 ]
Kakeji, Yoshihiro [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo, Japan
[2] Kobe Univ, Grad Sch Med, Dept Surg, Div Minimally Invas Surg, Kobe, Hyogo, Japan
关键词
CHARACTERISTIC ROC CURVE; SURVIVAL; SCORE;
D O I
10.1245/s10434-022-11868-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Multidisciplinary treatment combining neoadjuvant treatment (NAT) and surgery has slightly improved the prognosis of patients with esophageal squamous cell carcinoma (ESCC). Although various biomarkers targeting nutrition and inflammation are associated with cancer prognosis, most studies have focused on conditions prior to NAT. Developing real-time and sensitive biomarkers that monitor changes in systemic conditions during NAT is important. We established a novel nutritional and inflammatory index, represented as the albumin to derived neutrophil-to-lymphocyte ratio (Alb-dNLR), and calculated the change in Alb-dNLR (Delta Alb-dNLR) during neoadjuvant chemotherapy (nCT). In this study, we aimed to evaluate whether Delta Alb-dNLR is associated with prognosis in patients with ESCC. Methods We investigated 172 patients who underwent nCT before esophagectomy between April 2010 and March 2018. The dNLR was calculated as the ratio of neutrophil count to (white blood cell count - neutrophil count), Alb-dNLR was calculated by dividing the serum albumin level by the dNLR, and Delta Alb-dNLR was evaluated by dividing the post-Alb-dNLR by the pre-Alb-dNLR. Patients were divided into 'high' and 'low' groups according to the Delta Alb-dNLR. Results Thirty-nine patients (22.7%) had a low Delta Alb-dNLR (<= 0.8), and the 5-year overall survival (OS) rates in patients with low and high Delta Alb-dNLR were 38.1% and 53.6%, respectively (p = 0.0072). Multivariate analyses demonstrated that estimated blood loss (p = 0.044), pathological T stage (p = 0.0005), pathological N stage (p = 0.017), and Delta Alb-dNLR (p = 0.005) were independent prognostic factors for OS. Conclusions Delta Alb-dNLR is a useful prognostic factor for OS in patients with ESCC receiving nCT.
引用
收藏
页码:6860 / 6866
页数:7
相关论文
共 50 条
  • [21] The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma
    Xiao, Qin
    Zhang, Baihua
    Deng, Xiang
    Wu, Jie
    Wang, Hui
    Wang, Yonggang
    Wang, Wenxiang
    PLOS ONE, 2016, 11 (12):
  • [22] A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma Neutrophil lymphocyte ratio/prealbumin ratio
    Lv, Yajuan
    Zhang, Jiandong
    Liu, Zhen
    Tian, Yuan
    Liu, Fengjun
    MEDICINE, 2019, 98 (07)
  • [23] Prognostic value of neutrophil-to-lymphocyte ratio in patients with esophageal adenocarcinoma
    Wang, Y.
    ANNALS OF ONCOLOGY, 2017, 28 : 167 - 167
  • [24] ASO Author Reflections: Decrease of Albumin and Derived Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy Reflect the Worse Prognosis in Patients with Esophageal Squamous Cell Carcinoma
    Tomoki Abe
    Taro Oshikiri
    Hironobu Goto
    Takashi Kato
    Manabu Horikawa
    Ryuichiro Sawada
    Hitoshi Harada
    Naoki Urakawa
    Hiroshi Hasegawa
    Shingo Kanaji
    Kimihiro Yamashita
    Takeru Matsuda
    Yoshihiro Kakeji
    Annals of Surgical Oncology, 2022, 29 : 6867 - 6868
  • [25] ASO Author Reflections: Decrease of Albumin and Derived Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy Reflect the Worse Prognosis in Patients with Esophageal Squamous Cell Carcinoma
    Abe, Tomoki
    Oshikiri, Taro
    Goto, Hironobu
    Kato, Takashi
    Horikawa, Manabu
    Sawada, Ryuichiro
    Harada, Hitoshi
    Urakawa, Naoki
    Hasegawa, Hiroshi
    Kanaji, Shingo
    Yamashita, Kimihiro
    Matsuda, Takeru
    Kakeji, Yoshihiro
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (11) : 6867 - 6868
  • [26] Reply regarding prognostic value of neutrophil-to-lymphocyte ratio in laryngeal squamous cell carcinoma
    Wong, B. Y. Winson
    Stafford, Nicholas D.
    Green, Victoria L.
    Greenman, John
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (03): : 615 - 615
  • [27] The Prognostic Value of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio in Patients With Laryngeal Squamous Cell Carcinoma
    Cai, Hao
    Zhang, Zi-Heng
    Zhou, Yu-Jie
    Liu, Ji
    Chen, Huan-Qi
    Lin, Ren-Yu
    ENT-EAR NOSE & THROAT JOURNAL, 2021, 100 (10) : 731 - 736
  • [28] Prognostic value of the neutrophil-to-lymphocyte ratio in patients with laryngeal squamous cell carcinoma: a meta-analysis
    Chen K.
    Zhao R.
    Tang Y.
    Comparative Clinical Pathology, 2021, 30 (5) : 857 - 870
  • [29] Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma
    Li, Xing
    Chen, Zhan-Hong
    Ma, Xiao-Kun
    Chen, Jie
    Wu, Dong-Hao
    Lin, Qu
    Dong, Min
    Wei, Li
    Wang, Tian-Tian
    Ruan, Dan-Yun
    Lin, Ze-Xiao
    Xing, Yan-Fang
    Deng, Yun
    Wu, Xiang-Yuan
    Wen, Jin-Yun
    TUMOR BIOLOGY, 2014, 35 (11) : 11057 - 11063
  • [30] Significance of the neutrophil-to-lymphocyte ratio in young patients with oral squamous cell carcinoma
    Zhang, Baixia
    Du, Wei
    Gan, Kang
    Fang, Qigen
    Zhang, Xu
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7597 - 7603